Central Nervous System Glioma
1 clinical trials · Condition
◉ Watch Central Nervous System Glioma
| Record | Firm | Date |
|---|---|---|
| Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. (NCT03363217) | St. Justine's Hospital | 2018-08-16 |
Track Central Nervous System Glioma automatically
Every clearance here is in the API, with alerts when new ones post.